+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 90Years
All Genders
ID06920134

Safety and Early Effectiveness of ARC-IM Therapy Using Epidural Electrical Stimulation to Manage Blood Pressure in Parkinsons Disease

Led by Ecole Polytechnique Fédérale de Lausanne · Updated on 2026-07-07

5

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and early effectiveness of ARC-IM Therapy, which involves epidural electrical stimulation, to help manage blood pressure in people with typical or atypical Parkinsons Disease who experience orthostatic hypotension. This study aims to support better hemodynamic control in this population and is sponsored by Ecole Polytechnique Fdrale de Lausanne. Participants will receive the ARC-IM Investigational System, which includes implantation of a stimulation lead on the lower thoracic spinal cord and a neurostimulator in the abdominal area. All participants will use this implantable device during the study, with no placebo or comparison group. The therapys configuration and effects will be monitored over time. During the study, participants will undergo various tests and assessments including orthostatic head-up tilt tests, symptom questionnaires, mobility and balance tests, and user satisfaction surveys at set intervals after therapy configuration. Researchers will track device safety throughout the study, which may last up to five years. Participants will attend scheduled visits to evaluate therapy usability and monitor health outcomes.

CONDITIONS

Brief Title

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Research Team

G

Gregoire Courtine, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here